The Taming of Nuclear Factor Erythroid-2-Related Factor-2 (Nrf2) Deglycation by Fructosamine-3-Kinase (FN3K)-Inhibitors-A Novel Strategy to Combat Cancers Narasimha M. Beeraka et al, 2021, Cancers CrossRef
A Unique Anti-Cancer 3-Styrylchromone Suppresses Inflammatory Response via HMGB1-RAGE Signaling Hideaki Abe et al, 2021, Medicines CrossRef
Cross-talks in colon cancer between RAGE/AGEs axis and inflammation/immunotherapy. Annachiara Mollace et al, 2021, Oncotarget CrossRef
Network Pharmacology-Based Study to Uncover Potential Pharmacological Mechanisms of Korean Thistle (Cirsium japonicum var. maackii (Maxim.) Matsum.) Flower against Cancer Ki-Kwang Oh et al, 2021, Molecules CrossRef
Impact of Advanced Glycation End products (AGEs) and its receptor (RAGE) on cancer metabolic signaling pathways and its progression Yadav Sangeeta Muthyalaiah et al, 2022, Glycoconj J CrossRef
Dual Nature of RAGE in Host Reaction and Nurturing the Mother–Infant Bond Yu Oshima et al, 2022, IJMS CrossRef
Curcumin, thymoquinone, and 3, 3′-diindolylmethane combinations attenuate lung and liver cancers progression Amna A. Saddiq et al, 2022, Front. Pharmacol. CrossRef
Therapeutic potential of targeting the receptor for advanced glycation end products (RAGE) by small molecule inhibitors Harbinder Singh et al, 2022, Drug Development Research CrossRef
Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury Shengnan Cao et al, 2022, Disease Markers CrossRef
A Review on Inhibition of RAGE via Marine Sources, Herbal Sources and Food Substances null Dr. Rahul Wagh et al, 2022, IJARSCT CrossRef
Nanoformulations of Anti-cancer Agents: Present Status & Future
Directions Urvashi Garg et al, 2022, CNANOM CrossRef
Effects of Maillard reaction and its product AGEs on aging and age-related diseases Huan Peng et al, 2024 CrossRef